OncLive: Dr. Mesa on navigating the expanding paradigm of JAK Inhibitors in MPNs

In this video, Ruben A. Mesa, MD, director of the Mays Cancer Center, discusses strategies for navigating the expanding paradigm of JAK inhibitors in myeloproliferative neoplasms.

Watch here



Share This Article!
Article Categories: Cancer, In the News